Free Trial

Sonnet BioTherapeutics (SONN) SEC Filings & 10K Form

Sonnet BioTherapeutics logo
$2.90 -0.02 (-0.68%)
(As of 11/21/2024 ET)

Recent Sonnet BioTherapeutics SEC Filings

DateFilerForm TypeView
11/08/2024
7:30 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
8:22 AM
Sonnet BioTherapeutics (Filer)
Form 424B4
11/06/2024
11:15 PM
Sonnet BioTherapeutics (Filer)
Form EFFECT
11/06/2024
8:22 AM
Sonnet BioTherapeutics (Filer)
Form S-1/A
11/06/2024
7:48 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
8:01 AM
Sonnet BioTherapeutics (Filer)
Form S-1/A
10/28/2024
8:01 AM
Sonnet BioTherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/17/2024
7:50 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
7:56 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:30 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
7:36 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
4:15 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
7:30 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
4:27 PM
Sonnet BioTherapeutics (Filer)
Form DEF 14A
08/19/2024
4:28 PM
Sonnet BioTherapeutics (Filer)
Form ARS
08/19/2024
7:50 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:41 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:45 AM
Sonnet BioTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
4:28 PM
Sonnet BioTherapeutics (Filer)
Form PRE 14A
07/24/2024
7:36 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
11:15 PM
Sonnet BioTherapeutics (Filer)
Form EFFECT
07/15/2024
4:05 PM
Sonnet BioTherapeutics (Filer)
Form 424B3
07/05/2024
3:06 PM
Sonnet BioTherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/20/2024
3:49 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
7:15 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
6:35 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
8:25 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
11:15 PM
Sonnet BioTherapeutics (Filer)
Form EFFECT
05/14/2024
4:25 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
7:30 AM
Sonnet BioTherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/03/2024
7:00 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
6:30 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
3:20 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
6:35 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
6:30 AM
Sonnet BioTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/04/2024
11:15 PM
Sonnet BioTherapeutics (Filer)
Form EFFECT
12/27/2023
3:56 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
3:31 PM
Sonnet BioTherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/15/2023
3:30 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SONN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners